QINLOCK 50mg tablets DECIPHERA PHARMACEUT ORIGINAL MEDICINE
Chemical substance: ripretinib
Active substance
Results for the substance ripretinib
1 result
About this active substance
Ripretinib is a medication used for the treatment of advanced or metastatic gastrointestinal stromal tumors (GIST) in patients who have failed other therapies. It acts as a kinase inhibitor, blocking signaling that promotes tumor growth.
The medication is taken orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor the response to therapy.
Patients should be aware of potential side effects, such as nausea, fatigue, or muscle pain. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, fatigue, and muscle pain. In rare cases, severe reactions such as heart failure or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
The medication is taken orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor the response to therapy.
Patients should be aware of potential side effects, such as nausea, fatigue, or muscle pain. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, fatigue, and muscle pain. In rare cases, severe reactions such as heart failure or allergic reactions may occur. Patients should be informed of these risks before starting treatment.